AVNS - CIK 0001606498
AVANOS MEDICAL, INC. trades as AVNS and has a market capitalization of $1.17 B, making it the #2523 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $701.20M, up 1.9% from the prior year and net income of -$72.90M. This page tracks AVANOS MEDICAL, INC. through 701 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years AVANOS MEDICAL, INC.'s revenue grew from $566.20M to $701.20M, a compound annual growth rate of 2.4%. Net profit margin compressed from 7.0% to -10.4% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 |
| Insider trade | 4 | 2026-05-12 |
| Insider trade | 4 | 2026-05-12 |
| Insider trade | 4 | 2026-05-12 |
| Insider trade | 4 | 2026-05-12 |
| Insider trade | 4 | 2026-05-12 |
| SCHEDULE 13G/A | - | 2026-05-07 |
| SCHEDULE 13G/A | - | 2026-05-07 |
Delivered double-digit organic growth led by Specialty Nutrition Systems segment; Generated $0.11 of diluted earnings per share and $0.22 of adjusted ...
In the fourth quarter of 2024, net sales totaled $179.6 million, a 3.6% increase compared to the prior year, primarily due to continued strong performance.
We expect 2026 net sales to be between $700 million and $720 million, and adjusted diluted earnings per share are expected to be between $0.90 ...
The largest companies sharing AVANOS MEDICAL, INC.'s SEC industry classification (orthopedic, prosthetic & surgical appliances & supplies).
AVANOS MEDICAL, INC. (AVNS) has a market capitalization of $1.17 B as of 2026-06-10, ranking #2523 among US-listed companies.
AVANOS MEDICAL, INC. reported revenue of $701.20M for fiscal year 2025, an increase of 1.9% year over year.
In its latest fiscal year AVANOS MEDICAL, INC. reported a net loss of $72.90M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.